World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Microbiology 73 1620 1468 120 107 298 30208

Michael Hoelscher publications per year

The chart shows the history of publications by Michael Hoelscher between 1991 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Michael Hoelscher published across 36 years, from 1991 to 2026, averaging 10.8 papers a year. Output peaked at 40 publications in 2021. 24 of the 388 publications appeared in the last two years.

No. of publications
10 20 30 40
Bar chart. Horizontal axis: year, 1991 to 2026. Vertical axis: number of publications, 0 to 40. Peak 40 publications in 2021. 1991: 1 publication 1992: 0 publications 1993: 1 publication 1994: 1 publication 1995: 0 publications 1996: 0 publications 1997: 0 publications 1998: 1 publication 1999: 1 publication 2000: 2 publications 2001: 1 publication 2002: 4 publications 2003: 4 publications 2004: 1 publication 2005: 7 publications 2006: 2 publications 2007: 5 publications 2008: 3 publications 2009: 7 publications 2010: 14 publications 2011: 12 publications 2012: 22 publications 2013: 18 publications 2014: 13 publications 2015: 19 publications 2016: 27 publications 2017: 24 publications 2018: 12 publications 2019: 20 publications 2020: 26 publications 2021: 40 publications 2022: 24 publications 2023: 30 publications 2024: 22 publications 2025: 23 publications 2026: 1 publication
1991 2026

388 publications in total across all disciplines

View publications per year as a table
Michael Hoelscher: publications per year, 1991 to 2026
Year Publications
1991 1
1992 0
1993 1
1994 1
1995 0
1996 0
1997 0
1998 1
1999 1
2000 2
2001 1
2002 4
2003 4
2004 1
2005 7
2006 2
2007 5
2008 3
2009 7
2010 14
2011 12
2012 22
2013 18
2014 13
2015 19
2016 27
2017 24
2018 12
2019 20
2020 26
2021 40
2022 24
2023 30
2024 22
2025 23
2026 1
Total 388
Download as CSV

Michael Hoelscher publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Michael Hoelscher sits on this spectrum.

No. of scientists
50 100 150 200 250
Bar chart with 64 bars. Horizontal axis: publications, 55–64 to 679+. Vertical axis: number of scientists, 0 to 288. Most scientists, 288, have 135–144 publications. The last bar groups every scientist with 679 publications or more. The highlighted bar, 295–304 publications, is where this scientist sits. 55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55–64 publications 679+

This scientist: 298 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

View publications distribution as a table
Number of Microbiology scientists by publication count, Research.com 2026 ranking edition. Based on 5,513 ranked scientists.
Publications Scientists This scientist
55–64 8
65–74 29
75–84 55
85–94 112
95–104 137
105–114 190
115–124 235
125–134 234
135–144 288
145–154 265
155–164 264
165–174 253
175–184 276
185–194 190
195–204 234
205–214 208
215–224 198
225–234 155
235–244 161
245–254 160
255–264 146
265–274 139
275–284 148
285–294 115
295–304 96 298
305–314 88
315–324 106
325–334 65
335–344 76
345–354 64
355–364 62
365–374 65
375–384 61
385–394 34
395–404 44
405–414 36
415–424 35
425–434 29
435–444 33
445–454 34
455–464 25
465–474 26
475–484 20
485–494 19
495–504 16
505–514 17
515–524 23
525–534 14
535–544 14
545–554 18
555–564 12
565–574 7
575–584 9
585–594 9
595–604 9
605–614 7
615–624 9
625–634 7
635–644 4
645–654 5
655–664 6
665–674 7
675–678 3
679+ 99
Download as CSV

Michael Hoelscher D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael Hoelscher sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 88 bars. Horizontal axis: D-Index, 40 to 127+. Vertical axis: number of scientists, 0 to 162. Most scientists, 162, have 58 D-Index. The last bar groups every scientist with 127 D-Index or more. The highlighted bar, 73 D-Index, is where this scientist sits. 40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 73 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

View D-Index distribution as a table
Number of Microbiology scientists by D-index, Research.com 2026 ranking edition. Based on 5,513 ranked scientists.
D-Index Scientists This scientist
40 30
41 86
42 90
43 117
44 122
45 123
46 108
47 110
48 106
49 109
50 129
51 111
52 116
53 127
54 134
55 134
56 112
57 136
58 162
59 151
60 139
61 123
62 126
63 144
64 109
65 103
66 124
67 112
68 103
69 131
70 94
71 93
72 96
73 92 73
74 80
75 66
76 87
77 60
78 73
79 59
80 57
81 55
82 47
83 77
84 50
85 45
86 42
87 41
88 32
89 38
90 35
91 34
92 27
93 26
94 33
95 22
96 37
97 22
98 21
99 22
100 30
101 16
102 20
103 17
104 19
105 16
106 19
107 18
108 14
109 10
110 9
111 7
112 11
113 6
114 15
115 10
116 12
117 7
118 10
119 10
120 11
121 2
122 7
123 12
124 5
125 9
126 6
127+ 95
Download as CSV

Overview

Michael Hoelscher is affiliated with Ludwig-Maximilians-Universität München in Germany and specializes in Medicine, with a significant focus on Infectious Diseases. Their research spans multiple subfields including Epidemiology, Modeling and Simulation, Molecular Biology, and Surgery. The scientist's work primarily addresses topics related to SARS-CoV-2 and COVID-19, Tuberculosis, as well as pneumonia and respiratory infections.

The researcher has contributed extensively to studies involving COVID-19 clinical research, COVID-19 epidemiological studies, Mycobacterium research and diagnosis, and SARS-CoV-2 detection and testing.

Michael Hoelscher's recent publications include the following notable papers:

  • Virological assessment of hospitalized patients with COVID-2019 (2020, Nature)
  • Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany (2020, New England Journal of Medicine)
  • Virological assessment of hospitalized cases of coronavirus disease 2019 (2020, bioRxiv (Cold Spring Harbor Laboratory))
  • Author Correction: Virological assessment of hospitalized patients with COVID-2019 (2020, Nature)
  • SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies (2022, Science)

Frequent co-authors collaborating with Michael Hoelscher include:

  • Christof Geldmacher
  • Andreas Wieser
  • Inge Kroidl
  • Norbert Heinrich
  • Noemi Castelletti

The scientist regularly publishes in venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • SSRN Electronic Journal
  • BMC Infectious Diseases
  • Nature Communications
  • Frontiers in Immunology

Best Publications

  • Virological assessment of hospitalized patients with COVID-2019.

    Roman Wölfel;Victor M. Corman;Wolfgang Guggemos;Michael Seilmaier

  • Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.

    Camilla Rothe;Mirjam Schunk;Peter Sothmann;Gisela Bretzel

  • Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test

    Stephen D Lawn;Peter Mwaba;Peter Mwaba;Matthew Bates;Amy Piatek

  • Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial

    Grant Theron;Lynn Zijenah;Duncan Chanda;Petra Clowes;Petra Clowes

  • Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages.

    David Stucki;David Stucki;Daniela Brites;Daniela Brites;Leïla Jeljeli;Mireia Coscolla;Mireia Coscolla

  • Operational Feasibility of Using Loop-Mediated Isothermal Amplification for Diagnosis of Pulmonary Tuberculosis in Microscopy Centers of Developing Countries

    Catharina C. Boehme;Pamela Nabeta;German Henostroza;Rubhana Raqib

  • New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects

    Alimuddin I Zumla;Alimuddin I Zumla;Stephen H Gillespie;Michael Hoelscher;Patrick P J Philips

  • High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

    Martin J Boeree;Norbert Heinrich;Rob Aarnoutse;Andreas H Diacon

  • Evaluation of the Xpert MTB/RIF Assay for the Diagnosis of Pulmonary Tuberculosis in a High HIV Prevalence Setting

    Grant Theron;Jonny Peter;Richard van Zyl-Smit;Hridesh Mishra

  • Host-directed therapies for infectious diseases: current status, recent progress, and future prospects

    Alimuddin Zumla;Alimuddin Zumla;Martin Rao;Martin Rao;Robert S Wallis;Stefan H E Kaufmann

  • Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts

    Ben J Marais;Knut Lönnroth;Stephen D Lawn;Stephen D Lawn;Giovanni Battistai Migliori

  • Drug-resistant tuberculosis: time for visionary political leadership

    Ibrahim Abubakar;Ibrahim Abubakar;Matteo Zignol;Dennis Falzon;Mario Raviglione

  • A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis

    M.J. Boeree;A.H. Diacon;R. Dawson;K. Narunsky

  • Clinical presentation and virological assessment of hospitalized cases of coronavirus disease 2019 in a travel-associated transmission cluster

    Woelfel R;Corman Vm;Guggemos W;Seilmaier M

  • Single-Dose Azithromycin versus Penicillin G Benzathine for the Treatment of Early Syphilis

    Gabriele Riedner;Mary Rusizoka;Jim Todd;Leonard Maboko

  • Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial

    Jonny G Peter;Lynn S Zijenah;Duncan Chanda;Duncan Chanda;Petra Clowes;Petra Clowes

  • Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers

    Robert S Wallis;Markus Maeurer;Peter Mwaba;Jeremiah Chakaya

  • Preferential infection and depletion of Mycobacterium tuberculosis–specific CD4 T cells after HIV-1 infection

    Christof Geldmacher;Njabulo Ngwenyama;Alexandra Schuetz;Constantinos Petrovas

  • Tuberculosis Diagnostics and Biomarkers: Needs, Challenges, Recent Advances, and Opportunities

    Ruth McNerney;Markus Maeurer;Ibrahim Abubakar;Ibrahim Abubakar;Ben Marais

  • Tuberculosis treatment and management—an update on treatment regimens, trials, new drugs, and adjunct therapies

    Alimuddin Zumla;Jeremiah Chakaya;Rosella Centis;Lia D'Ambrosio

  • Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study

    Josephine M Bryant;Simon R Harris;Julian Parkhill;Rodney Dawson

  • Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis

    C. Boehme;E. Molokova;F. Minja;S. Geis

  • CD8 T-Cell Recognition of Multiple Epitopes within Specific Gag Regions Is Associated with Maintenance of a Low Steady-State Viremia in Human Immunodeficiency Virus Type 1-Seropositive Patients

    Christof Geldmacher;Jeffrey R. Currier;Eva Herrmann;Antelmo Haule

  • Rapid and Accurate Detection of Mycobacterium tuberculosis in Sputum Samples by Cepheid Xpert MTB/RIF Assay-A Clinical Validation Study

    Andrea Rachow;Alimuddin Zumla;Norbert Heinrich;Gabriel Rojas-Ponce

  • New Drugs for the Treatment of Tuberculosis: Needs, Challenges, Promise, and Prospects for the Future

    Christian Lienhardt;Mario Raviglione;Mel Spigelman;Richard Hafner

Frequent Co-Authors

Alimuddin Zumla
Alimuddin Zumla University College London
Markus Maeurer
Markus Maeurer Champalimaud Foundation
Keertan Dheda
Keertan Dheda University of Cape Town
Stephen H. Gillespie
Stephen H. Gillespie University of St Andrews
Timothy D. McHugh
Timothy D. McHugh University College London
Deborah L. Birx
Deborah L. Birx Centers for Disease Control and Prevention
Merlin L. Robb
Merlin L. Robb Walter Reed Army Institute of Research
Ibrahim Abubakar
Ibrahim Abubakar University College London
Ben J. Marais
Ben J. Marais University of Sydney
Francine E. McCutchan
Francine E. McCutchan Columbia University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in microbiology, exploring related online degrees can open doors to diverse career options. Accelerated medical billing and coding certificate online programs offer a quick pathway into healthcare administration, which complements the scientific knowledge gained in microbiology studies.

Additionally, numerous online medical degrees provide flexible options for students balancing work and education. These programs can enhance understanding of clinical applications, expanding career possibilities beyond the lab.

Public health professionals often pursue a Master of Public Health, and some choose online MPH programs easy to get into to start fast. Combining microbiology with public health expertise is valuable in disease prevention and community health initiatives.

For those interested in specialized care roles, becoming a child specialist is another option. The child specialist salary reflects the growing demand for professionals who support children's health and development, which aligns with microbiology’s emphasis on human health sciences.

Best Scientists Citing Michael Hoelscher

Trending Scientists

Recently Published Articles